Drug Type Small molecule drug |
Synonyms 阿莫西林氨溴索 |
Target |
Mechanism SCNA modulators(Sodium channel alpha subunit modulators), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H19Br2ClN2O |
InChIKeyQNVKOSLOVOTXKF-PFWPSKEQSA-N |
CAS Registry23828-92-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Bronchitis | Phase 1 | CN | - | 07 May 2014 |
Acute respiratory infections | Phase 1 | CN | - | 07 May 2014 |
Asthma | Phase 1 | CN | - | 07 May 2014 |
Asthmatic bronchitis | Phase 1 | CN | - | 07 May 2014 |
Bronchiectasis | Phase 1 | CN | - | 07 May 2014 |
Bronchitis, Chronic | Phase 1 | CN | - | 07 May 2014 |
Otitis Media | Phase 1 | CN | - | 07 May 2014 |
Pharyngitis | Phase 1 | CN | - | 07 May 2014 |
respiratory tract; infection, chronic | Phase 1 | CN | - | 07 May 2014 |